Pharmaceutical company stocks soar after 'breakthrough' development in curing problem affecting up to 80% of men
One pharmaceutical company's stock price saw a significant jump after they revealed news of a 'breakthrough' cure, as it could solve a problem that affects up to 80 percent of men across the globe.
Hair loss is something that many have simply accepted as an inevitability when it comes to aging, as most men especially will end up losing some or all of their locks over the years.
It's something that affects some far quicker than others though, with androgenetic alopecia – otherwise known as male pattern baldness – hitting people as early as their 20s, with many running into rapidly receding hair lines in their 30s and 40s.
Modern 'solutions' have seen people take trips to Türkiye to undergo increasingly popular hair transplants that are impressively rejuvenating, and others either opt for the comparatively simple toupee or simply decide to shave it all off and embrace baldness.
Advert
Following news that scientists appear to have found hints of a solution for hair loss, one company has revealed a fascinating new discovery, as they have seemingly 'cured' androgenetic alopecia following clinical trials.
As shared by Global Cosmetics News, Swiss pharmaceutical company Cosmo Pharmaceuticals has been on the receiving end of a 24 percent stock value bump after they revealed statistically significant results from two late-stage hair loss treatment trials.
The 'cure' in question is Cosmo's clascoterone cream, which saw a staggering 539 percent relative improvement in target-area hair count in one clinical test compared to placebo results, with the second providing a 168 percent improvement.
What this means in simple terms is that people could soon be able to use this clascoterone cream to 'cure' their hair loss and baldness, effectively restoring the hair to the point it was before.
Considering the rate at which this issue affects people across the globe, having a simple 'cure' would be a major breakthrough for Cosmo and its understandable why many investors have chosen to put their faith and money in the company following the promising results.
The global hair loss therapeutics market is currently valued in the billions, so if Cosmo's clascoterone cream could replace that entirely then it would emerge as one of the world's major players.
"Throw it on my head right now," writes one Reddit user eager for any proven solution to their current hair situation, with another adding that "the world isn't ready for me with hair again."
Some remain skeptical that this will end up being the miracle cure it's touted by some as being though, with a third comment writing: "How long has the cure for baldness been labeled as being right around the corner? Has to be since the 80s."
Another speculated that "no doubt it'll also cause your teeth to fall out or something equally terrible because we should be so lucky."